Search

everythinglearnresearchcommunity

for

Search:↓

Most pregnant women experience common skin changes like linea nigra and stretch marks.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Some medications can cause acne, and stopping these drugs is the main treatment.

Cosmetics enhance beauty, fix defects, and intimidate enemies, with varying cultural standards and alternative methods.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Laser hair reduction near the eyebrows can cause serious eye injuries even with safety measures.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Many skin patients also have mental health issues, and doctors should treat both together.

Consider benefits and risks of new alopecia treatments for safety.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The conclusion of the case is not provided in the summary.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.